栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/05 | 2,210 | 2,220 | 2,208 | 2,220 | +10 | +0.5% | 29,800 |
| 2024/07/04 | 2,206 | 2,220 | 2,191 | 2,210 | +14 | +0.6% | 71,400 |
| 2024/07/03 | 2,202 | 2,211 | 2,179 | 2,196 | -6 | -0.3% | 62,000 |
| 2024/07/02 | 2,192 | 2,210 | 2,174 | 2,202 | +20 | +0.9% | 73,100 |
| 2024/07/01 | 2,241 | 2,241 | 2,177 | 2,182 | -58 | -2.6% | 63,800 |
| 2024/06/28 | 2,250 | 2,250 | 2,204 | 2,240 | +20 | +0.9% | 103,100 |
| 2024/06/27 | 2,205 | 2,220 | 2,182 | 2,220 | +5 | +0.2% | 105,500 |
| 2024/06/26 | 2,215 | 2,225 | 2,193 | 2,215 | +10 | +0.5% | 138,600 |
| 2024/06/25 | 2,192 | 2,211 | 2,185 | 2,205 | +18 | +0.8% | 80,400 |
| 2024/06/24 | 2,156 | 2,193 | 2,150 | 2,187 | +53 | +2.5% | 97,000 |
| 2024/06/21 | 2,160 | 2,164 | 2,125 | 2,134 | -26 | -1.2% | 214,600 |
| 2024/06/20 | 2,145 | 2,167 | 2,136 | 2,160 | +20 | +0.9% | 77,700 |
| 2024/06/19 | 2,154 | 2,166 | 2,122 | 2,140 | -11 | -0.5% | 50,900 |
| 2024/06/18 | 2,112 | 2,154 | 2,112 | 2,151 | +67 | +3.2% | 92,100 |
| 2024/06/17 | 2,060 | 2,084 | 2,029 | 2,084 | +17 | +0.8% | 69,800 |
| 2024/06/14 | 2,015 | 2,098 | 2,015 | 2,067 | +54 | +2.7% | 165,200 |
| 2024/06/13 | 2,064 | 2,064 | 1,999 | 2,013 | -51 | -2.5% | 135,600 |
| 2024/06/12 | 2,022 | 2,077 | 2,022 | 2,064 | +30 | +1.5% | 80,100 |
| 2024/06/11 | 2,045 | 2,057 | 2,028 | 2,034 | -5 | -0.2% | 70,600 |
| 2024/06/10 | 2,024 | 2,041 | 2,018 | 2,039 | +24 | +1.2% | 63,400 |
| 2024/06/07 | 2,009 | 2,019 | 1,998 | 2,015 | +8 | +0.4% | 43,300 |
| 2024/06/06 | 2,011 | 2,019 | 1,994 | 2,007 | +1 | ±0% | 65,300 |
| 2024/06/05 | 1,995 | 2,016 | 1,991 | 2,006 | +6 | +0.3% | 64,300 |
| 2024/06/04 | 2,031 | 2,063 | 2,000 | 2,000 | -81 | -3.9% | 169,400 |
| 2024/06/03 | 2,100 | 2,104 | 2,080 | 2,081 | -16 | -0.8% | 54,100 |
| 2024/05/31 | 2,052 | 2,097 | 2,052 | 2,097 | +27 | +1.3% | 280,400 |
| 2024/05/30 | 2,042 | 2,074 | 2,022 | 2,070 | +9 | +0.4% | 150,700 |
| 2024/05/29 | 2,033 | 2,068 | 2,020 | 2,061 | -10 | -0.5% | 91,800 |
| 2024/05/28 | 2,084 | 2,089 | 2,056 | 2,071 | -11 | -0.5% | 70,900 |
| 2024/05/27 | 2,036 | 2,085 | 2,003 | 2,082 | +44 | +2.2% | 75,200 |
| 2024/05/24 | 2,030 | 2,049 | 2,022 | 2,038 | -19 | -0.9% | 81,500 |
| 2024/05/23 | 2,044 | 2,079 | 2,038 | 2,057 | -15 | -0.7% | 75,300 |
| 2024/05/22 | 2,080 | 2,089 | 2,051 | 2,072 | -28 | -1.3% | 114,800 |
| 2024/05/21 | 2,146 | 2,170 | 2,100 | 2,100 | -46 | -2.1% | 88,800 |
| 2024/05/20 | 2,136 | 2,176 | 2,107 | 2,146 | -1 | ±0% | 109,500 |
| 2024/05/17 | 2,120 | 2,153 | 2,094 | 2,147 | +30 | +1.4% | 109,600 |
| 2024/05/16 | 2,109 | 2,130 | 2,082 | 2,117 | +14 | +0.7% | 140,100 |
| 2024/05/15 | 2,150 | 2,160 | 2,092 | 2,103 | -67 | -3.1% | 160,700 |
| 2024/05/14 | 2,212 | 2,212 | 2,148 | 2,170 | +97 | +4.7% | 288,300 |
| 2024/05/13 | 2,041 | 2,076 | 2,009 | 2,073 | +32 | +1.6% | 143,700 |
| 2024/05/10 | 2,051 | 2,103 | 2,017 | 2,041 | +57 | +2.9% | 193,800 |
| 2024/05/09 | 2,004 | 2,018 | 1,973 | 1,984 | -20 | -1% | 101,900 |
| 2024/05/08 | 2,034 | 2,042 | 1,996 | 2,004 | -26 | -1.3% | 72,900 |
| 2024/05/07 | 2,030 | 2,041 | 2,015 | 2,030 | +3 | +0.1% | 58,200 |
| 2024/05/02 | 2,011 | 2,027 | 2,001 | 2,027 | +24 | +1.2% | 32,200 |
| 2024/05/01 | 2,000 | 2,010 | 1,977 | 2,003 | -2 | -0.1% | 58,500 |
| 2024/04/30 | 2,008 | 2,012 | 1,983 | 2,005 | -2 | -0.1% | 70,200 |
| 2024/04/26 | 2,003 | 2,023 | 1,988 | 2,007 | -18 | -0.9% | 94,400 |
| 2024/04/25 | 2,022 | 2,037 | 2,004 | 2,025 | +20 | +1% | 147,600 |
| 2024/04/24 | 2,000 | 2,015 | 1,997 | 2,005 | -1 | ±0% | 45,500 |
201～
250
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| あすかＨＤ | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
